Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis.

There is no consensus about short-term suboptimal response to first-line treatments in relapsing-remitting multiple sclerosis.